Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion

Neuroscience Letters

Volumn 329, Issue 2, 2002, Pages 165-168

  Cutillas, Blanca ^a   Ambrosio, Santiago ^a   Unzeta, Mercedes ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

6 Hydroxydopamine; Monoamine oxidase B inhibitor; Neuroprotection; Parkinsonism; PF 9601N

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; N (2 PROPYNYL) 2 (5 BENZYLOXYINDOLYL)METHYLAMINE; OXIDOPAMINE; PF 9601N; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; AMINE OXIDASE (FLAVIN CONTAINING); INDOLE DERIVATIVE; METHYLAMINE; N (2 PROPYNYL) 2 (5 BENZYLOXY INDOLYL) METHYLAMINE; N-(2-PROPYNYL)-2-(5-BENZYLOXY-INDOLYL) METHYLAMINE; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL COUNT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TREATMENT OUTCOME; ANIMAL; COMPARATIVE STUDY; DEGENERATIVE DISEASE; ENZYMOLOGY; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ANIMALS; INDOLES; METHYLAMINES; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0037199660     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00614-6     Document Type: Article

References (27)

1. The effect of side-chain substitution at positions 2 and 3 of the heterocyclic ring of N-acetylenic analogues of tryptamine as monoamine oxidase inhibitors
2. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats
3. The potentiation of the anti-akinetic effect after L-DOPA treatment by an inhibitor of MAO-B, l-deprenyl
4. Positron emission tomography after MPTP: Observations relating to the cause of Parkinson's disease
5. Free radicals oxidative stress and neurodegeneration
6. Acetylenic and allenic derivatives of 2-(5-metoxyindolyl) and 2-(5-hidroxyindolyl) methylamines: Synthesis and in vitro evaluation as monoamine oxidase inhibitors
7. Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration
8. Selegiline in the treatment of Alzheimer's disease: A long-term randomized placebo-controlled trial Czech and Slovak Senile Dementia of Alzheimer type study group
9. Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine
10. Mechanism of 6-hydroxydopamine neurotoxicity
11. Protection against dopaminergic neurotoxicity of MPTP by monoamine oxidase inhibitors
12. The primary site of dopamine neuron damage in Parkinson's disease: Substantia nigra or striatum?
13. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo
14. The striatal dopamine dependency of life-span in male rats: Longevity study with l-deprenyl
15. Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo
16. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease
17. + ion
18. The effect of l-deprenyl and levodopa on the progression of PD
19. PF 9601N attenuates MPTP-induced depletion of striatal dopamine levels in C57/Bl 6 mice
20. Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition
21. Involvement of Ca2+ in dopamine release in striatal rat slices by PF 9601N and l-deprenyl
22. The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning on 6-hydroxydopamine lesioned rats
23. Antioxidant activity and suppression of hydroxyl radical formation by N-(2-propynyl)2-(5-benzyloxy-indol) methylamine (PF 9601N) and related acetylenic tryptamine derivatives
24. DATATOP: A decade of neuroprotective inquiry. Parkinson Study Group: Deprenyl and tocopherol, antioxidative therapy of Parkinsonism
25. Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line
26. + toxicity in vivo
27. Neurochemical and neuroprotective effects of some aliphatic propargylamines: New selective nonamphetamine-like monoamine oxidase B inhibitors